Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Roland J. Levinsky"'
Autor:
Roland J. Levinsky, Kimberly Gilmour, Manfred Schmidt, Joanna Sinclair, John L. Smith, Abdulaziz Al Ghonaium, H. Bobby Gaspar, Marianne Antonius Jakobsen, Christine Kinnon, Kathryn L. Parsley, Doug King, Christof von Kalle, Torben Barington, Robin R. Ali, Harry N White, Gaby Brouns, Hans Ole Christensen, Adrian J. Thrasher, Steven J. Howe
Publikováno v:
The Lancet. 364:2181-2187
X-linked severe combined immunodeficiency (SCID-X1) is caused by mutations in the common cytokine-receptor gamma chain (gamma(c)), resulting in disruption of development of T lymphocytes and natural-killer cells. B-lymphocyte function is also intrins
Autor:
Robin R. Ali, M De Alwis, Roland J. Levinsky, Stephen L. Hart, Adrian J. Thrasher, S. C. Inglis, Christine Kinnon, Xiaoliu Zhang, F. W. Fitzke, Mike Boursnell
Publikováno v:
Human Gene Therapy. 10:2527-2537
Production of high-titer rAAV is essential for in vivo clinical application. One limiting factor may be the failure of existing systems to replicate the packaging genome in such a way that expression of Rep and Cap proteins is coordinately amplified.
Autor:
R P Harbottle, Carolina V. Arancibia-Cárcamo, Roland J. Levinsky, Margreet A. Wolfert, Leonard W. Seymour, Robin R. Ali, Carolina Mailhos, Daniel F P Larkin, A Knight, Adrian J. Thrasher, Stephen L. Hart, Andrew J.T. George, Christine Kinnon, Nicola O’Reilly, Charles Coutelle
Publikováno v:
Human Gene Therapy. 9:575-585
Nonviral vectors consisting of integrin-targeting peptide/DNA (ID) complexes have the potential for widespread application in gene therapy. The transfection efficiency of this vector, however, has been limited by endosomal degradation. We now report
Publikováno v:
Clinical and Experimental Immunology. 111:231-236
Mutations in the Bruton's tyrosine kinase (BTK) gene result in XLA. Despite the large numbers of BTK mutations reported, no correlation can be made between the clinical phenotype and the gene defects. Analysis of Btk protein expression and activity i
Publikováno v:
Blood. 87:3722-3730
The primary immunodeficiencies are attractive candidates for the development of gene therapy approaches based on the transduction of hematopoietic cells. We have constructed a high-titer recombinant retrovirus for expression of gp91-phox, deficiencie
Autor:
Ruth C. Lovering, Roland J. Levinsky, S. Hinshelwood, Christine Kinnon, Giles O. Cory, L. Maccarthy-Morrogh
Publikováno v:
The Journal of Experimental Medicine
X-linked agammaglobulinemia, a B cell immunodeficiency, is caused by mutations in the Bruton's tyrosine kinase (Btk) gene. The absence of a functional Btk protein leads to a failure of B cell differentiation and antibody production. B cell receptor s
Publikováno v:
Journal of Medical Genetics. 31:717-720
We describe a family affected by X linked severe combined immunodeficiency (SCIDX1) in which genetic prediction of carrier status was made using X chromosome inactivation studies together with limited genetic linkage analysis. Linkage studies in this
Publikováno v:
Immunology Today. 14:554-558
The btk gene has recently been identified as the causative gene in X-linked agammaglobulinemia (XLA). This has opened up many new possibilities for the treatment of this B-cell immunodeficiency. Christine Kinnon and colleagues review the high degree
Autor:
Alison Jones, Christine Kinnon, Ruth C. Lovering, Sally Genet, Mahesh de Alwis, Helen Middleton-Price, Sue Malcolm, Gareth Morgan, Roland J. Levinsky, Lesley A. Alterman
Publikováno v:
Journal of Immunological Methods. 166:111-116
We report the development of a relatively quick and simple method for the assessment of X inactivation status for carrier determination in families affected by X-linked agammaglobulinemia (XLA). This method utilises an immunomagnetic separation techn
Publikováno v:
Blood. 82:2196-2202
Chronic granulomatous disease (CGD) is an inherited immunodeficiency resulting from the inability of an individual's phagocytes to produce superoxide anions because of defective NADPH oxidase. The disease may be treated by bone marrow transplantation